No Record Found
No Record Found
Sector
PharmaceuticalsOpen
₹743Prev. Close
₹744.1Turnover(Lac.)
₹31.13Day's High
₹746.65Day's Low
₹742.852 Week's High
₹84252 Week's Low
₹556.15Book Value
₹134.44Face Value
₹2Mkt Cap (₹ Cr.)
5,983.09P/E
32.8EPS
22.66Divi. Yield
0.132 Sep 2025
12:00 AM
AGM
Announcement Date: 02 Sep, 2025
5 Nov 2025
12:00 AM
Board Meeting
Agenda : Audited Result
27 May 2025
12:00 AM
Dividend
Dividend Amount: 1
Record Date: 05 Sep, 2025
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 16.1 | 16.1 | 16.1 | 16.1 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 980.66 | 799.27 | 683.36 | 599.59 |
Net Worth | 996.76 | 815.37 | 699.46 | 615.69 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 |
|---|---|
Revenue | 385.36 |
yoy growth (%) | |
Raw materials | -128.12 |
As % of sales | 33.24 |
Employee costs | -32.76 |
| Y/e 31 Mar( In .Cr) | Mar-2021 |
|---|---|
Profit before tax | 167.31 |
Depreciation | -6.76 |
Tax paid | -43.71 |
Working capital | |
Other operating items |
| Y/e 31 Mar | Mar-2021 |
|---|---|
Growth matrix (%) | |
Revenue growth | |
Op profit growth | |
EBIT growth | |
Net profit growth |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,700.7 | 87.3 | 4,08,018.91 | 564.22 | 0.94 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,355.5 | 67.13 | 1,68,751.74 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 4,003.7 | 63.51 | 1,35,542.32 | 597 | 0.15 | 2,707 | 249.82 |
Cipla Ltd CIPLA | 1,434.5 | 22.29 | 1,15,882.86 | 1,210.53 | 1.12 | 4,495.16 | 411.56 |
Lupin Ltd LUPIN | 2,195.9 | 18.79 | 1,00,267.34 | 1,357.35 | 0.55 | 3,852.79 | 595.98 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / Managing Director
Satish Waman Wagh
E D & Wholetime Director
Smita Satish Wagh
E D & Wholetime Director
Saloni Satish Wagh
E D & Wholetime Director
Shivani Satish Wagh
E D & Wholetime Director
Balasaheb G. Sawant
Independent Non Exe. Director
Dileep Kumar Jain
Independent Non Exe. Director
Dinesh N Modi
Independent Non Exe. Director
Neelam Yashpal Arora
Independent Non Exe. Director
Ganapati D Yadav
Independent Non Exe. Director
Sunil Subhash Bhagwat
Company Sec. & Compli. Officer
Prachi Sathe
207/208 Udyog Bhavan,
Sonawala Road Goregaon (East),
Maharashtra - 400063
Tel: 91-22-40332727
Website: http://www.supriyalifescience.com
Email: cs@supriyalifescience.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Supriya Lifescience Limited was initially constituted on October 29, 1985, as a Partnership Firm under the name M/s Supriya Chemicals. The Partnership Firm was last re-constituted pursuant to a Partne...
Read More
Reports by Supriya Lifescience Ltd
What is the Supriya Lifescience Ltd share price today?
What is the Market Cap of Supriya Lifescience Ltd?
What is the PE and PB ratio of Supriya Lifescience Ltd?
What is the 52 Week High and Low of Supriya Lifescience Ltd?
What is the CAGR of Supriya Lifescience Ltd?
What is the shareholding pattern of Supriya Lifescience Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
